Grifols (GRFS) Cash from Operations (2010 - 2020)
Grifols (GRFS) posted Cash from Operations of 116320951.13 for Q1 2020, down 69.02% quarter-over-quarter from 375465153.7 in Q4 2019, and up 161.02% year-on-year from 44564177.7 in Q2 2019.
Grifols (GRFS) Cash from Operations (2010 - 2020) Analysis & Trends
Grifols (GRFS) has reported Cash from Operations for 10 consecutive years, with 116320951.13 the latest figure, recorded in Q1 2020.
- Cash from Operations for Q1 2020 came in at 116320951.13, up 161.02% year-over-year; the trailing twelve-month figure through Mar 2020 was 767696482.23 (up 33.15% YoY), and the FY2025 annual result was 1218753559.89, up 26.44% from the prior year.
- Cash from Operations was 116320951.13 for Q1 2020 at Grifols, down from 375465153.7 in the prior quarter.
- Over five years, Cash from Operations peaked at 671810029.36 in Q4 2017 and troughed at 190630846.21 in Q1 2019.
- Average Cash from Operations over 5 years is 234197285.45, with a median of 194784409.05 recorded in 2016.
- Year-over-year, Cash from Operations surged 244.9% in 2017 and slumped 267.38% in 2019.
- Over 5 years, Cash from Operations stood at 194784409.05 in 2016, then soared by 244.9% to 671810029.36 in 2017, then tumbled by 30.55% to 466541223.61 in 2018, then declined by 19.52% to 375465153.7 in 2019, then slumped by 69.02% to 116320951.13 in 2020.
- Per Business Quant data, the three most recent Cash from Operations figures were 116320951.13 in Q1 2020, 375465153.7 in Q4 2019, and 190630846.21 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 5.33 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.51 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.83 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.92 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.19 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.54 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.62 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 116.32 Mn |
| Mar 31, 2020 | 116.32 Mn |
| Dec 31, 2019 | 375.47 Mn |
| Dec 31, 2019 | 375.47 Mn |
| Mar 31, 2019 | -190.63 Mn |
| Mar 31, 2019 | -190.63 Mn |
| Dec 31, 2018 | 466.54 Mn |
| Dec 31, 2018 | 466.54 Mn |
| Jun 30, 2018 | 186.75 Mn |
| Jun 30, 2018 | 186.75 Mn |
| Mar 31, 2018 | 113.89 Mn |
| Mar 31, 2018 | 113.89 Mn |
| Dec 31, 2017 | 671.81 Mn |
| Dec 31, 2017 | 671.81 Mn |
| Jun 30, 2017 | 256.39 Mn |
| Jun 30, 2017 | 256.39 Mn |
| Mar 31, 2017 | 154.89 Mn |
| Mar 31, 2017 | 154.89 Mn |
| Dec 31, 2016 | 194.78 Mn |
| Dec 31, 2016 | 194.78 Mn |